News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,283 Results
Type
Article (42977)
Company Profile (276)
Press Release (657030)
Section
Business (205362)
Career Advice (2019)
Deals (35541)
Drug Delivery (95)
Drug Development (81545)
Employer Resources (170)
FDA (16229)
Job Trends (14924)
News (347065)
Policy (32721)
Tag
Academia (2616)
Alliances (49795)
Alzheimer's disease (1321)
Approvals (16205)
Artificial intelligence (201)
Bankruptcy (360)
Best Places to Work (11724)
Biotechnology (201)
Breast cancer (226)
Cancer (1723)
Cardiovascular disease (129)
Career advice (1680)
CAR-T (123)
Cell therapy (360)
Clinical research (65619)
Collaboration (669)
Compensation (371)
COVID-19 (2600)
C-suite (163)
Data (1638)
Diabetes (211)
Diagnostics (6354)
Earnings (85730)
Employer resources (147)
Events (111773)
Executive appointments (567)
FDA (17135)
Funding (607)
Gene therapy (258)
GLP-1 (654)
Government (4389)
Healthcare (18886)
Infectious disease (2711)
Inflammatory bowel disease (121)
Interviews (314)
IPO (16522)
Job creations (3651)
Job search strategy (1431)
Layoffs (445)
Legal (7939)
Lung cancer (259)
Manufacturing (235)
Medical device (13273)
Medtech (13278)
Mergers & acquisitions (19390)
Metabolic disorders (553)
Neuroscience (1728)
NextGen: Class of 2025 (6579)
Non-profit (4543)
Northern California (2097)
Obesity (309)
Opinion (198)
Patents (164)
People (57244)
Phase I (20489)
Phase II (28896)
Phase III (21502)
Pipeline (714)
Postmarket research (2583)
Preclinical (8698)
Radiopharmaceuticals (242)
Rare diseases (335)
Real estate (5937)
Regulatory (22098)
Research institute (2412)
Resumes & cover letters (352)
Southern California (1800)
Startups (3621)
United States (18567)
Vaccines (622)
Weight loss (210)
Date
Today (11)
Last 7 days (596)
Last 30 days (2494)
Last 365 days (34644)
2025 (4455)
2024 (35480)
2023 (40319)
2022 (51526)
2021 (56037)
2020 (54397)
2019 (46868)
2018 (35298)
2017 (32458)
2016 (31917)
2015 (37926)
2014 (31652)
2013 (26838)
2012 (29017)
2011 (29667)
2010 (27744)
Location
Africa (741)
Arizona (212)
Asia (38004)
Australia (6256)
California (4794)
Canada (1718)
China (393)
Colorado (217)
Connecticut (236)
Europe (82004)
Florida (690)
Georgia (165)
Illinois (456)
Indiana (260)
Maryland (742)
Massachusetts (3637)
Michigan (198)
Minnesota (334)
New Jersey (1352)
New York (1367)
North Carolina (847)
Northern California (2097)
Ohio (173)
Pennsylvania (1108)
South America (1115)
Southern California (1800)
Texas (705)
Utah (143)
Washington State (480)
700,283 Results for "atossa genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Societal CDMO Enters Agreement With Atossa Therapeutics to Provide Clinical Trial Services (CTS) for Innovative Selective Estrogen Receptor Modulator
Societal CDMO, Inc. today announced that it has been selected by Atossa Therapeutics (Nasdaq: ATOS ) to provide a range of its Clinical Trial Services (CTS) offerings focused on Atossa’s proprietary Selective Estrogen Receptor Modulator (SERM), (Z)-endoxifen.
May 23, 2023
·
5 min read
Press Releases
Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.
February 7, 2025
·
10 min read
Business
Atossa Therapeutics and Quantum Leap Healthcare Provide Enrollment Update for (Z)-Endoxifen Arm of Ongoing I-SPY 2 Clinical Trial
Atossa Therapeutics, Inc. and Quantum Leap Healthcare Collaborative™ (“Quantum Leap”) today announced that six patients have been dosed with Atossa’s proprietary Selective Estrogen Receptor Modulator (SERM), (Z)-endoxifen, in the ongoing Phase 2 I-SPY 2 clinical trial.
June 28, 2023
·
6 min read
BioForest
Atossa Therapeutics and Quantum Leap Healthcare Announce New Study Arm to Evaluate (Z)-Endoxifen in the Ongoing I-SPY 2 Clinical Trial
Atossa Therapeutics, Inc. (Nasdaq: ATOS) and Quantum Leap Healthcare Collaborative™ today announce that Atossa’s proprietary Selective Estrogen Receptor Modulator (SERM), (Z)-endoxifen, will be evaluated in a new study arm of the ongoing I-SPY 2 clinical trial.
March 21, 2023
·
8 min read
Press Releases
Myriad Genetics Introduces Online Prenatal Genetic Testing Resource
January 23, 2025
·
4 min read
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that Genetics in Medicine, an official journal of the American College of Medical Genetics and Genomics (ACMG), published a new study validating RiskScore®, Myriad’s breast cancer risk assessment tool integrated into its MyRisk® Hereditary Cancer Test.
June 3, 2024
·
4 min read
Press Releases
Baylor Genetics Marks a Decade of Leadership in Precision Diagnostics, Empowering Patients, Healthcare Providers and Partners with Trusted Genetic Insights
February 12, 2025
·
4 min read
Press Releases
Melas Syndrome Market Size to Reach USD 494.2 Million by 2035, Impelled by Increasing Prevalence of Genetic Mutations
February 5, 2025
·
10 min read
Press Releases
Leber Congenital Amaurosis Market Expected to Exhibit a CAGR of 3.60% During 2025-2035, Impelled by Increasing Awareness and Genetic Testing.
February 3, 2025
·
10 min read
Press Releases
23andMe Launches New Genetic Report on Osteoporosis
January 31, 2025
·
5 min read
1 of 70,029
Next
